GOS prebiotic gains regulatory path to medical foods in Europe

Article

The listing for galactooligosaccharides in the European Union’s list of Novel Foods now mentions Foods for Special Medical Purposes (FSMPs).

Photo © Shutterstock.com/photofriday

Photo © Shutterstock.com/photofriday

Prebiotic ingredient galactooligosaccharides (GOS) is strengthening its position in the medical food industry in the European Union. The listing for galactooligosaccharides in the European Union’s list of approved Novel Foods now includes Foods for Special Medical Purposes (FSMPs).

The news was shared by UK-based prebiotics supplier Clasado Biosciences, which together with European FSMP producer GLNP Life Sciences submitted the petition to the European Food Safety Authority (EFSA). The companies’ press release reports: “Following a positive opinion from the European Food Safety Authority (EFSA) earlier this year, the European Commission, which oversees the Union list of Novel Foods, has now updated the entry for galactooligosaccharides (GOS) with the addition of FSMPs.”

In the press release, Lucie Nagy, Clasado general counsel, stated, “The amendment of the GOS entry in the Union List of Novel Foods to include Foods for Special Medical Purposes (FSMPs) unlocks more possibilities for nutrition-based healthcare product formulators.”

In the medical foods market, prebiotic GOS has the potential to support impaired gastrointestinal issues in hospitalized patients, the companies add.

Recent Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.